期刊
CURRENT OPINION IN PHARMACOLOGY
卷 24, 期 -, 页码 86-93出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2015.08.004
关键词
-
资金
- Agence Nationale de la recherche
- European Community's 7th Framework Program (BrainCAV) [222992]
- La Fondation pour la Recherche Medicale
- LabEx EpigenMed
- Fondation de France
- European Community's 7th Framework Program (BrainVectors) [286071]
- European Community's 7th Framework Program (ADVance) [290002]
Canine adenovirus type 2 (CAV-2) vectors are powerful tools for fundamental and applied neurobiology due to their negligible immunogenicity, preferential transduction of neurons, widespread distribution via axonal transport, and duration of expression in the mammalian brain. CAV-2 vectors are internalized in neurons by the selective use of coxsackievirus and adenovirus receptor (CAR), which is located at the presynapse in neurons. Neuronal internalization and axonal transport is mediated by CAR, which potentiates vector biodistribution. The above characteristics, together with the similar to 30 kb cloning capacity of helper-dependent (HD) CAV-2 vectors, optimized CAV-2 vector creation, production and purification, is expanding the therapeutic and fundamental options for CNS gene transfer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据